Daewoong Pharmaceutical Surpasses 1 Trillion Won in Sales for the First Time Last Year... 'Nabota' Drives Performance
[Asia Economy Reporter Dongwoo Lee] Daewoong Pharmaceutical announced on the 13th that its annual sales last year reached 1,005.2 billion KRW, surpassing 1 trillion KRW for the first time. This represents a 6.5% increase compared to the previous year. During the same period, operating profit was recorded at 31.4 billion KRW, up 2.2% from the previous year.
Hot Picks Today
"After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- [Breaking] KOSPI Surpasses 8,000 Points Intraday... Reaches 8,002.66P
- Even the Wealthy Ask, "Is It Okay to Enter Now?"... Flocking In With Cash Bundles [Wealth Investment Strategies] ⑨
- Tenant Steals 80 Million Won from Landlord's Bedroom... "Used for Debt Repayment, Burned 70 Million?"
- "He's Handsome, It's Such a Pity?"... Lawyer Responds to Bizarre 'Appearance Evaluation' of High School Girl Murder Suspect
Daewoong Pharmaceutical analyzed that balanced growth in ethical drugs (ETC) and over-the-counter drugs (OTC), along with exports of the botulinum toxin drug 'Nabota' to the United States, led to stable sales growth.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
